Search - tctmd.com

Displaying 701 - 720 of 744

Sort: Relevancy | Date

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

June 22, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

L.A. McKeown

June 22, 2015

News Industry News

Medtronic announces financial investment in Arsenal AAA, LLC

June 17, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

News Industry News

Milestone Pharmaceuticals Closes US$17 Million Series B Financing to Complete Phase 2 Clinical Studies for MSP-2017

June 15, 2015

News Industry News

Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation

June 10, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

Presentation TCT 2014

Patient And Occupational Dose Reduction Enabled By A Novel X-ray Imaging Technology For Interventional Cardiology: First Results

Presenter: Liesbeth Eloot

September 16, 2014

Presentation TCT 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Frank Litvack, Todd J. Brinton

September 14, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

December 05, 2013

News Daily News

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

December 05, 2013

Presentation TCT 2013

Novel Coronary Interventions

Presenter: David Moliterno

October 30, 2013

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

News Daily News

Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some

Caitlin E. Cox

July 25, 2013

News Daily News

Declaración Pública de Rehospitalizaciones PCI aunque Algunos Cuestionan los Resultados

Caitlin E. Cox

July 25, 2013

Advertisement

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

Medtronic announces financial investment in Arsenal AAA, LLC

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

Milestone Pharmaceuticals Closes US$17 Million Series B Financing to Complete Phase 2 Clinical Studies for MSP-2017

Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

Patient And Occupational Dose Reduction Enabled By A Novel X-ray Imaging Technology For Interventional Cardiology: First Results

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

Novel Coronary Interventions

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some

Declaración Pública de Rehospitalizaciones PCI aunque Algunos Cuestionan los Resultados

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content